Brainstorm Cell Therapeutics Inc (BCLI)
0.3711
-0.01
(-2.26%)
USD |
NASDAQ |
May 07, 16:00
0.37
0.00 (0.00%)
After-Hours: 18:33
Brainstorm Cell Therapeutics Cash from Investing (Quarterly): 0.196M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.196M |
| September 30, 2023 | -0.012M |
| June 30, 2023 | 0.004M |
| March 31, 2023 | 2.005M |
| December 31, 2022 | 1.038M |
| September 30, 2022 | -0.011M |
| June 30, 2022 | -0.012M |
| March 31, 2022 | -0.017M |
| December 31, 2021 | -1.297M |
| September 30, 2021 | 1.696M |
| June 30, 2021 | -0.039M |
| March 31, 2021 | -0.037M |
| December 31, 2020 | -0.302M |
| September 30, 2020 | -0.086M |
| June 30, 2020 | -2.07M |
| March 31, 2020 | -1.994M |
| December 31, 2019 | -0.345M |
| September 30, 2019 | 1.439M |
| June 30, 2019 | 1.391M |
| March 31, 2019 | 3.131M |
| December 31, 2018 | 3.968M |
| September 30, 2018 | 4.983M |
| June 30, 2018 | -13.03M |
| March 31, 2018 | 2.864M |
| December 31, 2017 | 2.745M |
| Date | Value |
|---|---|
| September 30, 2017 | -7.238M |
| June 30, 2017 | 6.78M |
| March 31, 2017 | 1.699M |
| December 31, 2016 | 0.788M |
| September 30, 2016 | 0.286M |
| June 30, 2016 | 0.137M |
| March 31, 2016 | 4.766M |
| December 31, 2015 | 0.898M |
| September 30, 2015 | 1.939M |
| June 30, 2015 | -0.555M |
| March 31, 2015 | -13.56M |
| December 31, 2014 | -2.757M |
| September 30, 2014 | -1.606M |
| June 30, 2014 | -0.002M |
| March 31, 2014 | -0.085M |
| December 31, 2013 | 4.781M |
| September 30, 2013 | -3.039M |
| June 30, 2013 | -0.057M |
| March 31, 2013 | 0.971M |
| December 31, 2012 | -2.765M |
| September 30, 2012 | -0.014M |
| June 30, 2012 | -0.009M |
| March 31, 2012 | -0.052M |
| December 31, 2011 | -0.018M |
| September 30, 2011 | -0.001M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-2.07M
Minimum
Jun 2020
2.005M
Maximum
Mar 2023
0.0814M
Average
-0.012M
Median
Jun 2022
Cash from Investing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 9.462M |
| iBio Inc | 0.00 |
| Theriva Biologics Inc | -0.056M |
| Oragenics Inc | -1.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.285M |
| Cash from Financing (Quarterly) | 3.352M |
| Free Cash Flow | -20.48M |
| Free Cash Flow Per Share (Quarterly) | -0.0637 |
| Free Cash Flow Yield | -128.2% |